![](/img/cover-not-exists.png)
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J Tabrizi, Ralf Reilmann, Raymund AC Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks, Christopher Kennard, Bernhard Landwehrmeyer, JuVolume:
11
Year:
2012
Language:
english
Pages:
12
DOI:
10.1016/s1474-4422(11)70263-0
File:
PDF, 1.03 MB
english, 2012